Guide

Controlled substances by telehealth: the flexibilities and the rulemaking

Summary

As of July 2026, clinicians may still prescribe controlled substances by telehealth without a prior in-person exam under federal flexibilities that have been extended, not made permanent. A separate DEA special registration framework has been proposed in rulemaking but is not yet in effect, so do not rely on it. You still need an active DEA registration, EPCS for electronic controlled prescriptions, and licensure in the state where the patient is located. Confirm the current expiration date before you prescribe.

By Gale Editorial · Updated 2026-07-27. Every figure cited to a dated source. How we write.

What are the current rules, as of July 2026?

As of July 2026, the federal flexibility that lets clinicians prescribe controlled substances by telehealth without a prior in-person examination remains in effect, because the DEA and HHS have extended it rather than allowing it to expire 1Ref 1U.S. Department of Health and Human Services (2026).Prescribing controlled substances via telehealth.The current extended federal flexibility for telemedicine prescribing of controlled substances without a prior in-person exam, and the special registration rulemaking in progress, as of July 2026.. This is an extension regime, not a permanent rule: it carries an expiration date that has been moved more than once, and the safe assumption is that it can change again. Check the current end date before you write.

The flexibility reaches scheduled medications across the controlled-substance schedules, including buprenorphine for opioid use disorder and the stimulants and benzodiazepines a behavioral-health prescriber commonly manages, subject to the conditions in the guidance. What it does not do is remove any of the baseline requirements below. Prescribing without an in-person exam is permitted for now, not permanently, and only when everything else is in order.

The special registration rulemaking: proposed, not in effect

The Ryan Haight Act has long required an in-person evaluation before prescribing a controlled substance, with a telemedicine special registration as the intended long-term exception. That special registration has been proposed through DEA rulemaking but is not yet finalized or available, which is exactly why the flexibilities keep being extended in the meantime 1Ref 1U.S. Department of Health and Human Services (2026).Prescribing controlled substances via telehealth.The current extended federal flexibility for telemedicine prescribing of controlled substances without a prior in-person exam, and the special registration rulemaking in progress, as of July 2026..

Do not build your practice around the proposed rule's terms. A proposed rule is not law, and its registration categories, limits, and conditions can shift before it takes effect. When it is finalized, its terms will replace the current extension regime, so the correct posture is to operate under today's extended flexibility and watch specifically for that rule to close.

Your DEA registration and EPCS still apply

None of the telehealth flexibility touches the baseline requirements. You still need an active DEA registration to prescribe any controlled substance, and electronic prescribing of controlled substances is mandated for Medicare Part D and by a growing number of states, so your e-prescribing setup has to support it 2Ref 2Drug Enforcement Administration (2026).Diversion Control Division.DEA Diversion Control Division administration of practitioner registration, EPCS requirements, and controlled-substance recordkeeping and inventory rules.. The DEA's Diversion Control Division administers registration, renewal, and modification, and it is the authority to check when a requirement is unclear.

The same division sets the recordkeeping and controlled inventory rules. A telehealth-only prescriber who never stocks medication has a lighter version of this, but the registration, the EPCS credentialing, and the recordkeeping obligations still attach to you personally. Calendar the DEA registration renewal the same way you calendar a license renewal, because a lapse there stops all controlled prescribing at once.

You still must be licensed where the patient is

A telehealth prescription is lawful only if you are authorized to practice, and to prescribe, in the state where the patient is physically located at the time of the visit 3Ref 3U.S. Department of Health and Human Services (2026).Licensure — Telehealth policy.That the prescriber must be authorized to practice in the state where the patient is located at the time of the visit.. That means both a medical or advanced-practice license in that state and, in many states, a separate state controlled-substance registration layered on top of your federal DEA registration. These state CSRs are the second controlled-substance license clinicians routinely forget.

Cross-border prescriptions fail quietly when one of these is missing: the pharmacy rejects the prescription, or worse, fills it and exposes you to a state you were never authorized to prescribe into. Before you prescribe to a patient in a new state, confirm your practice authority there and whether that state requires its own controlled-substance registration.

Video, audio-only, and what the visit has to be

Whether a controlled-substance visit can happen over audio only, or must use two-way video, depends on the drug and the current federal rules, which distinguish permanent telehealth provisions from the temporary flexibilities 4Ref 4U.S. Department of Health and Human Services (2026).Telehealth policy.The current federal telehealth policy distinguishing permanent provisions from temporary flexibilities, dated to July 2026.. For behavioral-health telehealth, Medicare's audio-only allowances are narrow and condition-specific, so a phone-only encounter may not support a controlled-substance decision even where the same visit would be covered for psychotherapy 5Ref 5Centers for Medicare & Medicaid Services (2025).Telehealth Services.Medicare behavioral-health telehealth rules, including the narrow, condition-specific audio-only allowances..

The conservative default is two-way audio-video for any controlled-substance encounter, because it satisfies the strictest reading and produces the cleanest record. Reserve audio-only for the situations the rules specifically permit, and document why audio-only was used when you rely on it. As with the prescribing flexibility, treat the audio-only rules as current to July 2026 and reconfirm them at renewal.

What to document and calendar

Treat controlled-substance telehealth as a dated arrangement you re-verify on a schedule. Calendar the current flexibility expiration date, your DEA registration renewal, and each state controlled-substance registration renewal, because a lapse in any one stops you from prescribing lawfully. Document the patient's physical location and identity, the clinical rationale, and a check of the state prescription-drug-monitoring program where the patient's state requires one.

Re-read the DEA Diversion Control Division and the HHS telehealth prescribing pages at each renewal, since this area changes by extension and rulemaking rather than on a fixed calendar. A one-line note in the chart recording that you confirmed current authority and the applicable rule on the date of service is cheap insurance against a rule that moved while you were not looking.

Common questions

As of July 2026, yes, under federal flexibilities the DEA and HHS have extended rather than made permanent. The flexibility currently allows telemedicine prescribing of controlled substances without a prior in-person exam, subject to conditions. Because it is an extension with an expiration date, confirm the rule is still in effect before you rely on it, and be authorized to prescribe where the patient is located.

No. A telemedicine special registration has been proposed through DEA rulemaking but is not finalized or available as of July 2026. The extended flexibilities exist precisely because that permanent pathway is not yet in place. Do not plan around the proposed rule's specific terms, since a proposed rule is not law and its details can change before it takes effect.

Often, yes. Many states require a separate state controlled-substance registration in addition to your federal DEA registration, held in the state where the patient is located. A federal DEA registration alone does not authorize a cross-state prescription. Confirm the requirement with the patient's state before prescribing, and calendar each state registration's renewal so none of them lapses.

It depends on the drug and the current federal rules, which separate permanent telehealth provisions from temporary flexibilities. Medicare's audio-only allowances for behavioral health are narrow, so a phone-only encounter may not support a controlled-substance decision even when it would be covered for psychotherapy. When the rule is unclear, use two-way video for any controlled-substance encounter.

This area changes by extension and rulemaking, not on a fixed calendar, so treat every date as provisional. Re-read the DEA Diversion Control Division and the HHS telehealth prescribing pages at each of your renewals, and note the current flexibility expiration date. If the special registration rule is finalized, its terms replace the extension regime, so watch for that transition specifically.

Run your practice on Gale

The software is free. Gale earns one flat 3.5% all-in per paid transaction — only on transactions that actually pay. No subscription, no setup fee, no network cut.

Start or manage a practice →

References

1.U.S. Department of Health and Human Services (2026). Prescribing controlled substances via telehealth. Telehealth.HHS.gov. linkThe current extended federal flexibility for telemedicine prescribing of controlled substances without a prior in-person exam, and the special registration rulemaking in progress, as of July 2026.
2.Drug Enforcement Administration (2026). Diversion Control Division. U.S. Drug Enforcement Administration. link ✓DEA Diversion Control Division administration of practitioner registration, EPCS requirements, and controlled-substance recordkeeping and inventory rules.
3.U.S. Department of Health and Human Services (2026). Licensure — Telehealth policy. Telehealth.HHS.gov. linkThat the prescriber must be authorized to practice in the state where the patient is located at the time of the visit.
4.U.S. Department of Health and Human Services (2026). Telehealth policy. Telehealth.HHS.gov. linkThe current federal telehealth policy distinguishing permanent provisions from temporary flexibilities, dated to July 2026.
5.Centers for Medicare & Medicaid Services (2025). Telehealth Services. CMS Medicare Learning Network (MLN901705). link ✓Medicare behavioral-health telehealth rules, including the narrow, condition-specific audio-only allowances.

https://www.gale.care/for-providers/th-controlled-substances-rules · 5 sources. Competitor details are cited to dated public sources and maintained as they change; figures are estimates, not commitments. Synthetic demonstration.

← Back to for providers